Skip to content

Section archive

Prostate Cancer

In a trial reported in the Journal of Clinical Endocrinology and Metabolism, 52 men with low-risk prostate cancer took 4,000 IU of vitamin D3 daily for a year, and most of those who finished saw their Gleason scores fall. David Marshall's team tracked PSA every two months and rebiopsied.

2 min read

78 stories